Vaccination of Oncology Patients: An Effective Tool and an Opportunity Not to Be Missed-Reference-Cited by-同舟云学术

Vaccination of Oncology Patients: An Effective Tool and an Opportunity Not to Be Missed

Published:2012-01-01 Issue:1 Volume:17 Page:1-2
ISSN:1083-7159
Container-title:The Oncologist
language:en
Short-container-title:

Author:

Kotton Camille N.¹²,Poznansky Mark C.¹²³

Affiliation:

1. a Infectious Diseases Division, Massachusetts General Hospital, Boston, Massachusetts, USA;

2. b Harvard Medical School, Boston, Massachusetts, USA;

3. c Vaccine and Immunotherapy Center, Infectious Diseases Division, Massachusetts General Hospital (East), Charlestown, Massachusetts, USA

Abstract

The manuscript by Xu et al., published in this issue of The Oncologist, examining the use of influenza vaccination in cancer patients undergoing active treatment is reviewed.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

https://pericles-gcp.literatumonline.com/doi/pdf/10.1634/theoncologist.2011-0383

Reference12 articles.

1. Low influenza vaccination rate among patients receiving chemotherapy for cancer;Loulergue;Ann Oncol,2008

2. Utility of influenza vaccination for oncology patients;Pollyea;J Clin Oncol,2010

3. Influenza vaccination in the organ transplant recipient: Review and summary recommendations;Kumar;Am J Transplant,2011

4. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: A global perspective;Tomblyn;Biol Blood Marrow Transplant,2009

5. Pandemic H1N1 influenza infection in adult transplant recipients;Bogoch;Transplantation,2011

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune response of COVID-19 vaccines in solid cancer patients: A meta-analysis;Human Vaccines & Immunotherapeutics;2024-05-24

2. Monoclonal Gammopathy of Undetermined Significance: A Comprehensive Review;Clinical Lymphoma Myeloma and Leukemia;2023-05

3. Secondary Immunodeficiency in Hematological Malignancies: Focus on Multiple Myeloma and Chronic Lymphocytic Leukemia;Frontiers in Immunology;2021-10-25

4. Reduced humoral immune response after BNT162b2 coronavirus disease 2019 messenger RNA vaccination in cancer patients under antineoplastic treatment;ESMO Open;2021-10

5. Monoclonal Gammopathy of Undetermined Significance (MGUS)—Not So Asymptomatic after All;Cancers;2020-06-12